2,254 Shares in Synopsys, Inc. (NASDAQ:SNPS) Bought by Semanteon Capital Management LP

Semanteon Capital Management LP purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 2,254 shares of the semiconductor company’s stock, valued at approximately $1,161,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. FMR LLC lifted its stake in shares of Synopsys by 8.9% in the third quarter. FMR LLC now owns 4,032,059 shares of the semiconductor company’s stock valued at $1,850,594,000 after purchasing an additional 330,206 shares during the period. Ameriprise Financial Inc. raised its position in shares of Synopsys by 20.3% in the third quarter. Ameriprise Financial Inc. now owns 2,041,275 shares of the semiconductor company’s stock valued at $925,744,000 after buying an additional 344,430 shares during the last quarter. Northern Trust Corp raised its position in shares of Synopsys by 4.9% in the third quarter. Northern Trust Corp now owns 1,687,602 shares of the semiconductor company’s stock valued at $774,559,000 after buying an additional 78,848 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Synopsys by 4.3% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 885,083 shares of the semiconductor company’s stock valued at $406,227,000 after buying an additional 36,470 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Synopsys by 0.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 826,010 shares of the semiconductor company’s stock valued at $379,114,000 after buying an additional 7,294 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Synopsys

In related news, CEO Sassine Ghazi sold 10,294 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $577.51, for a total transaction of $5,944,887.94. Following the transaction, the chief executive officer now owns 61,863 shares of the company’s stock, valued at $35,726,501.13. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Synopsys news, CEO Sassine Ghazi sold 10,294 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $577.51, for a total transaction of $5,944,887.94. Following the transaction, the chief executive officer now owns 61,863 shares in the company, valued at $35,726,501.13. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Roy Vallee sold 10,000 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $572.66, for a total value of $5,726,600.00. Following the transaction, the director now owns 20,000 shares in the company, valued at approximately $11,453,200. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,832 shares of company stock valued at $15,464,992. 0.66% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on SNPS shares. Piper Sandler began coverage on shares of Synopsys in a research report on Thursday, April 4th. They issued an “overweight” rating and a $665.00 price objective for the company. Robert W. Baird boosted their target price on shares of Synopsys from $624.00 to $640.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Needham & Company LLC restated a “buy” rating and issued a $660.00 target price on shares of Synopsys in a report on Friday, March 22nd. Rosenblatt Securities reiterated a “buy” rating and set a $615.00 price objective on shares of Synopsys in a research note on Thursday, March 21st. Finally, StockNews.com upgraded shares of Synopsys from a “hold” rating to a “buy” rating in a research note on Monday, March 18th. Eleven analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $601.00.

Synopsys Trading Up 0.5 %

SNPS traded up $2.59 on Thursday, reaching $530.11. The company had a trading volume of 915,482 shares, compared to its average volume of 1,240,382. The company has a fifty day moving average of $563.91 and a 200-day moving average of $535.52. The company has a market capitalization of $80.84 billion, a P/E ratio of 58.38, a PEG ratio of 3.08 and a beta of 1.06. Synopsys, Inc. has a one year low of $362.06 and a one year high of $629.38.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, February 21st. The semiconductor company reported $3.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.43 by $0.13. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Synopsys had a net margin of 22.96% and a return on equity of 22.88%. The firm’s revenue was up 21.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.75 earnings per share. Research analysts predict that Synopsys, Inc. will post 9.78 EPS for the current year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.